Technology Mapping as a New Mechanism for Managing Medicinal Product Development
https://doi.org/10.30895/1991-2919-2026-16-3-246-251
Abstract
In this interview, D.I. Fedorova, First Deputy Director of the Medical Technology Transfer Centre at the Scientific Centre for Expert Evaluation of Medicinal Products, describes practical, data-driven tools that support the management of scientific and technological development in the pharmaceutical sector. The central topic is technology mapping, an approach that enables a systems-level analysis of research directions, technology maturity levels, and implementation potential. The interview outlines how this tool can be used by government authorities and other decision-makers to adjust research priorities, allocate resources, and mitigate risks, and what value it provides to pharmaceutical and biotechnology companies when building development portfolios.
About the Author
D. I. FedorovaRussian Federation
Darya I. Fedorova
8/2 Petrovsky Blvd., Moscow 127051
Review
For citations:
Fedorova D.I. Technology Mapping as a New Mechanism for Managing Medicinal Product Development. Regulatory Research and Medicine Evaluation. 2026;16(3):246-251. (In Russ.) https://doi.org/10.30895/1991-2919-2026-16-3-246-251
JATS XML




























